The Seven Trial: Exploiting the Unfolded Protein Response

NCT06076837 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer Metastatic
Pancreatic Adenocarcinoma Metastatic

Interventions

DRUG: Botensilimab
DRUG: Balstilimab
DRUG: Chloroquine Phosphate
DRUG: Celecoxib
DRUG: Nab paclitaxel
DRUG: Gemcitabine
DRUG: Cisplatin

Sponsor

HonorHealth Research Institute

Collaborators

[object Object]
[object Object]